| | | Single nucleotide variant (non-coding transcript variant +2 more) | Melanoma, cutaneous malignant, susceptibility to, 3 | |
| | | Single nucleotide variant (non-coding transcript variant +2 more) | Melanoma, cutaneous malignant, susceptibility to, 3 | |
| | | Single nucleotide variant (synonymous variant +1 more) | Melanoma, cutaneous malignant, susceptibility to, 3 | |
| | | Single nucleotide variant (3 prime UTR variant +1 more) | Melanoma, cutaneous malignant, susceptibility to, 3 | |
| | | Single nucleotide variant (3 prime UTR variant) | Melanoma, cutaneous malignant, susceptibility to, 3 | |
| | | Single nucleotide variant (synonymous variant +1 more) | Melanoma, cutaneous malignant, susceptibility to, 3 | |
| | | Single nucleotide variant (synonymous variant +1 more) | Melanoma, cutaneous malignant, susceptibility to, 3 | |
| | | Microsatellite (3 prime UTR variant +1 more) | Melanoma, cutaneous malignant, susceptibility to, 3 | |
| | | Single nucleotide variant (non-coding transcript variant +2 more) | Melanoma, cutaneous malignant, susceptibility to, 3 | |
| | | Single nucleotide variant (synonymous variant +1 more) | Melanoma, cutaneous malignant, susceptibility to, 3 | |
| | | Single nucleotide variant (synonymous variant +1 more) | Melanoma, cutaneous malignant, susceptibility to, 3 | |
| | | Single nucleotide variant (non-coding transcript variant +2 more) | Melanoma, cutaneous malignant, susceptibility to, 3 | |
| | | Single nucleotide variant (3 prime UTR variant) | Melanoma, cutaneous malignant, susceptibility to, 3 | |
| | | Single nucleotide variant (synonymous variant +1 more) | Melanoma, cutaneous malignant, susceptibility to, 3 | |
| | | Single nucleotide variant (synonymous variant +1 more) | Melanoma, cutaneous malignant, susceptibility to, 3 | |
| | | Single nucleotide variant (synonymous variant +1 more) | Melanoma, cutaneous malignant, susceptibility to, 3 | |
| | | Single nucleotide variant (3 prime UTR variant) | Melanoma, cutaneous malignant, susceptibility to, 3 | |
| | | Single nucleotide variant (3 prime UTR variant +1 more) | Melanoma, cutaneous malignant, susceptibility to, 3 | |
| | | Single nucleotide variant (synonymous variant +1 more) | Melanoma, cutaneous malignant, susceptibility to, 3 | |
| | | Single nucleotide variant (synonymous variant +1 more) | Melanoma, cutaneous malignant, susceptibility to, 3 | |
| | | Single nucleotide variant (synonymous variant +1 more) | Melanoma, cutaneous malignant, susceptibility to, 3 | |
| | | Single nucleotide variant (3 prime UTR variant) | Melanoma, cutaneous malignant, susceptibility to, 3 | |
| | | Single nucleotide variant (synonymous variant +1 more) | Melanoma, cutaneous malignant, susceptibility to, 3 | |
| | | Single nucleotide variant (non-coding transcript variant +2 more) | Melanoma, cutaneous malignant, susceptibility to, 3 | |
| | | Single nucleotide variant (synonymous variant +1 more) | Melanoma, cutaneous malignant, susceptibility to, 3 | |
| | | Single nucleotide variant (synonymous variant +1 more) | Melanoma, cutaneous malignant, susceptibility to, 3 | |
| | | Single nucleotide variant (synonymous variant +1 more) | Melanoma, cutaneous malignant, susceptibility to, 3 | |
| | | Single nucleotide variant (3 prime UTR variant +1 more) | Melanoma, cutaneous malignant, susceptibility to, 3 | |
| | | Single nucleotide variant (synonymous variant +1 more) | Melanoma, cutaneous malignant, susceptibility to, 3 | |
| | | Single nucleotide variant (3 prime UTR variant +1 more) | Melanoma, cutaneous malignant, susceptibility to, 3 | |
| | | Single nucleotide variant (non-coding transcript variant +2 more) | Melanoma, cutaneous malignant, susceptibility to, 3 | |
| | | Single nucleotide variant (synonymous variant +1 more) | Melanoma, cutaneous malignant, susceptibility to, 3 | |
| | | Single nucleotide variant (non-coding transcript variant +2 more) | Melanoma, cutaneous malignant, susceptibility to, 3 | |
| | | Single nucleotide variant (synonymous variant +1 more) | Melanoma, cutaneous malignant, susceptibility to, 3 | |
| | | Single nucleotide variant (synonymous variant +1 more) | Melanoma, cutaneous malignant, susceptibility to, 3 | |
| | | Single nucleotide variant (synonymous variant +1 more) | Melanoma, cutaneous malignant, susceptibility to, 3 | |
| | | Single nucleotide variant (synonymous variant +1 more) | Melanoma, cutaneous malignant, susceptibility to, 3 | |
| | | Single nucleotide variant (3 prime UTR variant +1 more) | Melanoma, cutaneous malignant, susceptibility to, 3 | |
| | | Single nucleotide variant (missense variant) | not specified | |
| | | Single nucleotide variant (missense variant +1 more) | Hereditary cancer-predisposing syndrome | |
| | | Single nucleotide variant (synonymous variant +1 more) | Hereditary cancer-predisposing syndrome +1 more | |
| | | Single nucleotide variant (3 prime UTR variant +1 more) | Hereditary cancer-predisposing syndrome | |
| | | Deletion (frameshift variant +1 more) | Hereditary cancer-predisposing syndrome | |
| | | Microsatellite (intron variant +1 more) | not specified | |
| | | Duplication | Cataract 15 multiple types +3 more | |
| | | Single nucleotide variant (3 prime UTR variant +1 more) | Melanoma, cutaneous malignant, susceptibility to, 3 +1 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant +1 more) | Hereditary cancer-predisposing syndrome | |
| | | Single nucleotide variant (synonymous variant +1 more) | Hereditary cancer-predisposing syndrome | |
| | | Single nucleotide variant (missense variant +1 more) | Hereditary cancer-predisposing syndrome | |
| | | Single nucleotide variant (missense variant +1 more) | Hereditary cancer-predisposing syndrome | |
| | | Single nucleotide variant (missense variant +1 more) | Hereditary cancer-predisposing syndrome | |
| | | Deletion (frameshift variant +1 more) | Hereditary cancer-predisposing syndrome | |
| | | Single nucleotide variant (missense variant) | not specified | |
| | | Single nucleotide variant (missense variant +1 more) | not specified | |
| | | Single nucleotide variant (synonymous variant +1 more) | CDK4-related disorder | |
| | | Single nucleotide variant (missense variant +1 more) | Familial melanoma | |
| | | Single nucleotide variant (missense variant +1 more) | Familial melanoma +1 more | |
| | | Single nucleotide variant (missense variant +1 more) | Familial melanoma | |
| | | Single nucleotide variant (3 prime UTR variant +1 more) | Familial melanoma +1 more | |
| | | Single nucleotide variant (non-coding transcript variant +2 more) | Familial melanoma | |
| | | Single nucleotide variant (non-coding transcript variant +2 more) | Familial melanoma | |
| | | Single nucleotide variant (synonymous variant +1 more) | Familial melanoma | |
| | | Single nucleotide variant (missense variant +1 more) | Familial melanoma | |
| | | Single nucleotide variant (3 prime UTR variant +1 more) | Familial melanoma | |
| | | Single nucleotide variant (3 prime UTR variant +1 more) | Familial melanoma | |
| | | Single nucleotide variant (synonymous variant +1 more) | Familial melanoma | |
| | | Single nucleotide variant (missense variant +1 more) | Familial melanoma | |
| | | Single nucleotide variant (missense variant +1 more) | Familial melanoma | |
| | | Single nucleotide variant (synonymous variant +1 more) | Familial melanoma | |
| | | Single nucleotide variant (synonymous variant +1 more) | Familial melanoma | |
| | | Single nucleotide variant (missense variant +1 more) | Familial melanoma | |
| | | Single nucleotide variant (non-coding transcript variant +2 more) | Familial melanoma | |
| | | Single nucleotide variant (3 prime UTR variant +1 more) | Familial melanoma | |
| | | Single nucleotide variant (missense variant +1 more) | Familial melanoma | |
| | | Single nucleotide variant (missense variant +1 more) | Familial melanoma | |
| | | Single nucleotide variant (missense variant +1 more) | Familial melanoma | |
| | | Single nucleotide variant (nonsense +1 more) | Familial melanoma | |
| | | Single nucleotide variant (non-coding transcript variant +2 more) | Familial melanoma | |
| | | Single nucleotide variant (missense variant +1 more) | Familial melanoma | |
| | | Single nucleotide variant (synonymous variant +1 more) | Familial melanoma | |
| | | Single nucleotide variant (3 prime UTR variant +1 more) | Familial melanoma | |
| | | Single nucleotide variant (3 prime UTR variant +1 more) | not specified | |
| | | Single nucleotide variant (missense variant +1 more) | not specified | |
| | | Duplication (frameshift variant +1 more) | Hereditary cancer-predisposing syndrome | |
| | | Single nucleotide variant (5 prime UTR variant +2 more) | not specified | |
| | | Single nucleotide variant (missense variant +1 more) | Hereditary cancer-predisposing syndrome | |
| | | Single nucleotide variant (synonymous variant +1 more) | Hereditary cancer-predisposing syndrome | |
| | | Single nucleotide variant (missense variant +1 more) | Hereditary cancer-predisposing syndrome | |
| | | Single nucleotide variant (synonymous variant +1 more) | Hereditary cancer-predisposing syndrome | |
| | | Deletion (frameshift variant +2 more) | not provided | |
| | | Single nucleotide variant (missense variant +1 more) | not provided | |
| | | Single nucleotide variant (3 prime UTR variant +1 more) | not specified | |
| | | Single nucleotide variant (missense variant +1 more) | Hereditary cancer-predisposing syndrome | |
| | | Single nucleotide variant (missense variant +1 more) | Hereditary cancer-predisposing syndrome | |
| | | Copy number loss | not provided | |
| | | Single nucleotide variant (missense variant +1 more) | not specified | |
| | | Single nucleotide variant (missense variant +1 more) | Hereditary cancer-predisposing syndrome | |
| | | Single nucleotide variant (missense variant +1 more) | Hereditary cancer-predisposing syndrome | |
| | | Single nucleotide variant (synonymous variant +1 more) | Hereditary cancer-predisposing syndrome | |
| | | Single nucleotide variant (3 prime UTR variant +1 more) | Hereditary cancer-predisposing syndrome | |